Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy

Most of the current “literature” surrounding the presence of thrombosis in COVID-19 disease and appropriate prophylaxis/treatment modalities is certainly retrospective at best, and anecdotal at worst. But in these times of rapidly changing information and perspective, an assessment of all available...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbeddini, Ali, Gerochi, Rachel, Elshahawi, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586671/
https://www.ncbi.nlm.nih.gov/pubmed/33117545
http://dx.doi.org/10.1186/s40545-020-00274-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586671/
https://www.ncbi.nlm.nih.gov/pubmed/33117545
http://dx.doi.org/10.1186/s40545-020-00274-8

Ejemplares similares